High-Throughput Mechanistic Screening of Epigenetic Compounds for the Potential Treatment of Meningiomas

Background: Meningiomas are the most common primary central nervous system tumors. 20–30% of these tumors are considered high-grade and associated with poor prognosis and high recurrence rates. Despite the high occurrence of meningiomas, there are no FDA-approved compounds for the treatment of these...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatman, Philip D., Wroblewski, Tadeusz H., Fringuello, Anthony R., Scherer, Samuel R., Foreman, William B., Damek, Denise M., Lillehei, Kevin, Youssef, A. Samy, Jensen, Randy L., Graner, Michael W., Ormond, D. Ryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303324/
https://www.ncbi.nlm.nih.gov/pubmed/34300316
http://dx.doi.org/10.3390/jcm10143150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303324/
https://www.ncbi.nlm.nih.gov/pubmed/34300316
http://dx.doi.org/10.3390/jcm10143150

Ejemplares similares